* If the product has intellectual property rights, a license granted is must or contact us.
R-411 (free base)
Introduction of 220847-86-9 :
Valategrast (R-411 free base) is a potent and orally active integrin α4β1 (VLA-4) and α4β7 dual antagonist. Valategrast has the potential for Chronic obstructive pulmonary disease (COPD) and asthma treatment. IC50 & Target: Integrin α4β1; Integrin α4β7In Vitro: Valategrast contains a common l-phenylalanine-N-aroyl motif where the carboxylic acid is responsible for binding to the metal ion in the metal-ion-dependent adhesion site (MIDAS).